<unk><unk><unk>  (CAV) is the leading cause of morbidity and mortality beyond the first year after heart transplantation. In most<unk>  transplant centers coronary angiography currently remains the screening tool of choice for CAV. Early diagnosis is important as it may allow for alterations in medical therapy before the disease progresses to the stage where revascularization is required.
Cardiac allograft vasculopathy screening
Graft-versus-host disease screening
Acute tubular necrosis screening
Focal segmental glomerulosclerosis screening
Dilated cardiomyopathy screening
Granulomatosis with polyangiitis screening
HIV associated nephropathy screening
Diabetic nephropathy screening